Target intelligence / Profile preview

Ribosomal protein S20 pseudogene 2 (RPS20P2)

Target
RPS20P2
Molecular classification
Pseudogene, Other
01

Overview

Ribosomal protein S20 pseudogene 2 (RPS20P2) is classified as a pseudogene corresponding to the functional gene encoding ribosomal protein S20. Pseudogenes are non-functional DNA sequences similar to normal genes but are typically non-coding and lack the ability to produce functional protein. RPS20P2 itself does not encode a protein and is not considered a therapeutic target, receptor, enzyme, or a component of known molecular drug action pathways[8][7]. There are multiple processed pseudogenes for ribosomal protein S20 dispersed in the genome, but only the functional gene, RPS20, actively participates in ribosome biology[3][1]. No direct biological roles, disease implications, or drug interactions are known or reported for RPS20P2.

Other names
RPS20P2Ribosomal protein S20 (RPS20) pseudogeneENSG00000231547
02

Mechanism of action

Not applicable (does not encode functional product; not a target of therapy)

03

Biological functions

Not applicable (pseudogene; does not encode a functional protein)
04

Disease associations

None established (as a pseudogene, no direct disease association or function reported)
05

Safety considerations

None (not a therapeutic target, not linked to known toxicity or challenges)
06

Interacting drugs

None (no reported drug interactions for this pseudogene)
07

Biomarkers

None established

Beyond the preview

Go deeper on Ribosomal protein S20 pseudogene 2 (RPS20P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S20 pseudogene 2 (RPS20P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call